INS and type 2 diabetes mellitus: In this study, treatment with MLE (40 mg/kg B.W.)for 12 weeks significantly reduced fasting blood glucose (FBG), HbA1c, total cholesterol, triglycerides, serum insulin, and HOMA-IR values in T2DM rats compared with untreated diabetic controls.